These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29304754)

  • 21. Cancer driver gene discovery in transcriptional regulatory networks using influence maximization approach.
    Rahimi M; Teimourpour B; Marashi SA
    Comput Biol Med; 2019 Nov; 114():103362. PubMed ID: 31561101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying cancer driver genes based on multi-view heterogeneous graph convolutional network and self-attention mechanism.
    Peng W; Wu R; Dai W; Yu N
    BMC Bioinformatics; 2023 Jan; 24(1):16. PubMed ID: 36639646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Cancer Driver Modules Based on Graph Clustering from Multiomics Data.
    Zhang W; Wang SL; Liu Y
    J Comput Biol; 2021 Oct; 28(10):1007-1020. PubMed ID: 34529511
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of driver pathways using mutated gene network in cancer.
    Li F; Gao L; Ma X; Yang X
    Mol Biosyst; 2016 Jun; 12(7):2135-41. PubMed ID: 27118146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Multi-Omics Characteristics on Identification of Driver Genes Using Machine Learning Algorithms.
    Li F; Chu X; Dai L; Wang J; Liu J; Shang J
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
    Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
    J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computing microRNA-gene interaction networks in pan-cancer using miRDriver.
    Bose B; Moravec M; Bozdag S
    Sci Rep; 2022 Mar; 12(1):3717. PubMed ID: 35260634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types.
    Wei Y; Zhou L; Huang Y; Guo D
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovering potential cancer driver genes by an integrated network-based approach.
    Shi K; Gao L; Wang B
    Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of Cancer Gene Profiling Data.
    Roy J; Winter C; Schroeder M
    Methods Mol Biol; 2016; 1381():211-22. PubMed ID: 26667463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-cancer analysis of somatic mutations in miRNA genes.
    Urbanek-Trzeciak MO; Galka-Marciniak P; Nawrocka PM; Kowal E; Szwec S; Giefing M; Kozlowski P
    EBioMedicine; 2020 Nov; 61():103051. PubMed ID: 33038763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan-cancer.
    Chen Z; Huang J; Feng Y; Li Z; Jiang Y
    Cancer Med; 2020 Oct; 9(19):7279-7292. PubMed ID: 33094914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DGMP: Identifying Cancer Driver Genes by Jointing DGCN and MLP from Multi-omics Genomic Data.
    Zhang SW; Xu JY; Zhang T
    Genomics Proteomics Bioinformatics; 2022 Oct; 20(5):928-938. PubMed ID: 36464123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving existing analysis pipeline to identify and analyze cancer driver genes using multi-omics data.
    Nguyen QH; Le DH
    Sci Rep; 2020 Nov; 10(1):20521. PubMed ID: 33239644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer core modules identification through genomic and transcriptomic changes correlation detection at network level.
    Li W; Wang R; Bai L; Yan Z; Sun Z
    BMC Syst Biol; 2012 Jun; 6():64. PubMed ID: 22691569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel network control model for identifying personalized driver genes in cancer.
    Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
    PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
    Xu Q; Song A; Xie Q
    Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive identification of mutational cancer driver genes across 12 tumor types.
    Tamborero D; Gonzalez-Perez A; Perez-Llamas C; Deu-Pons J; Kandoth C; Reimand J; Lawrence MS; Getz G; Bader GD; Ding L; Lopez-Bigas N
    Sci Rep; 2013 Oct; 3():2650. PubMed ID: 24084849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.